Introduction: Inflammatory myofibroblastic tumors (IMT) while uncommon may arise within numerous organs. Historically, the literature regarding IMT has been confined to small one organ case series, with few reviews encompassing multiple anatomic sites, and little data regarding adjuvant treatment.
Methods: A review of patients with IMT treated at two large academic medical centers over a 15-year period was undertaken.